Annual revenue of top 10 big pharma companies

3 March 2020

According to market research, the worldwide pharmaceutical market was worth nearly $1.3 trillion in 20191 and the top 10 pharma companies accounted for around a third of sales ($392.5 billion).

Below is a graph of this year’s top 10 pharma companies, ranked by pharmaceutical revenue, along with a table with more on their performance compared to last year. Pfizer (NYSE: PFE) maintained pole position with full year revenues of $51.75 billion, but sales declined by 4% year-on-year as key drug patent expiries and Ibrance (palbociclib) and Lyrica (pregabalin) underperformed1.

Swiss pharma giants Roche2 (ROG: SIX) and Novartis3 (NOVN: VX) held onto second and third place, generating pharma revenues of 48.52 billion Swiss francs ($50.24 billion) and $47.45 billion, respectively.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK